OAOFY yields 20.94% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, OAOFY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OAOFY + PFE for your $10,000?
PJSC Tatneft, together with its subsidiaries, engages in exploration, development, and production of crude oil primarily in Russia. The company operates through Exploration and Production, Refining and Marketing, Petrochemical Products, and Banking segments. It holds interests in oil and gas fields located in Tatarstan in Russia. The company is also involved in the refining and marketing crude oil; the purchase and sale of crude oil and refined products from third parties; and retailing activities. In addition, it produces and sells tires; and manufactures and sells equipment, as well as provides engineering, procurement, and construction services for oil, gas, and petrochemical projects. Further, the company sells oilfield equipment, and auxiliary petrochemical related services and materials. Additionally, it is involved in the banking activities. The company was founded in 1950 and is headquartered in Almetyevsk, Russia.
Full OAOFY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.